Can Mycobacterium avium complex involve the bone marrow in patients with advanced HIV infection or other severe immunosuppression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can MAC Involve the Bone Marrow?

Yes, Mycobacterium avium complex (MAC) routinely involves the bone marrow in disseminated disease, particularly in patients with advanced HIV infection (CD4 <50 cells/µL), and bone marrow examination can be diagnostically valuable when blood cultures are negative or rapid diagnosis is needed. 1

Bone Marrow Involvement in Disseminated MAC

Pathophysiology and Frequency

  • Disseminated MAC is a multi-organ infection that characteristically involves most internal organs, including bone marrow, in patients with severe immunosuppression. 1, 2

  • Autopsy series demonstrate widespread organ involvement even when localizing symptoms are absent, confirming that bone marrow is routinely affected in disseminated disease. 2

  • The infection occurs almost exclusively when CD4 counts fall below 50 cells/µL, with median presentation at CD4 <25 cells/µL. 2

Clinical Manifestations of Bone Marrow Involvement

  • Hematologic abnormalities are hallmark features of disseminated MAC and reflect bone marrow involvement: 3, 1

    • Anemia (present in all patients, often severe with hematocrit <25%) 4, 5
    • Leukopenia (73% of cases) 4
    • Thrombocytopenia (45% of cases) 4
    • Pancytopenia (45% of cases) 4

  • The anemia associated with disseminated MAC is often "out of proportion to that expected for the stage of HIV disease," serving as a clinical clue to MAC involvement. 1

Diagnostic Utility of Bone Marrow Examination

When to Consider Bone Marrow Biopsy

Bone marrow aspiration, biopsy, and culture should be performed when: 5

  • Blood cultures are negative in symptomatic patients with suspected disseminated MAC
  • Rapid diagnosis is needed to initiate therapy promptly
  • Clinical features suggest MAC but microbiologic confirmation is lacking

High-yield clinical predictors for positive bone marrow findings include: 5

  • High fever
  • Prolonged duration of fever prior to examination
  • Elevated direct bilirubin

Diagnostic Yield

  • Blood cultures remain the gold standard, detecting >90% of disseminated MAC cases with a single positive culture. 2

  • Bone marrow culture sensitivity (63%) equals that of blood cultures, but does not exceed it. 5

  • Histopathologic examination of bone marrow provides unique diagnostic value: 5, 6

    • Identifies infection in approximately one-third of patients (34%) through visualization of granulomas and/or organisms 5
    • Detects infection in some culture-negative patients 5
    • Provides rapid diagnosis (mean 1.1 days) compared to culture (16-19 days) 6
    • Allows prompt initiation of therapy in one-third of patients 6

Histopathologic Patterns

Bone marrow specimens in disseminated MAC show characteristic but variable findings: 4, 7

  • Granulomas are present in 52% of cases, ranging from: 4

    • Small, subtle lymphohistiocytic aggregates (often initially missed)
    • Larger lymphohistiocytic lesions
    • Clusters of epithelioid histiocytes

  • Acid-fast bacilli (AFB) are rarely visualized on routine staining (seen in only one case in one series), despite positive cultures in 53% of specimens. 4

  • Immunohistochemical staining significantly improves organism detection: 7

    • Anti-M. duvalii antibodies: 91% sensitivity
    • Anti-BCG antibodies: 94% sensitivity
    • Kenyon stain: 57% sensitivity
    • Fite stain: 66% sensitivity

  • In AIDS patients, culture can be positive even in the absence of inflammation or AFB on staining, reflecting overwhelming infection in severely immunocompromised hosts. 4

Clinical Pitfalls and Caveats

Common Diagnostic Errors

  • Do not assume tuberculosis without appropriate testing—disseminated MAC can mimic TB clinically. 2

  • Subtle granulomas are frequently missed on initial review—almost half of lymphohistiocytic aggregates were overlooked in one series. 4

  • Negative AFB staining does not exclude MAC—organisms are rarely visible on routine acid-fast stains despite positive cultures. 4

Limitations of Bone Marrow Assessment

  • Bone marrow findings may not correlate with therapeutic response: 7

    • Patients showing decreased blood MAC colony counts after therapy did not demonstrate reduction in bone marrow organism burden
    • Bone marrow may provide a different perspective on infection status than blood cultures

  • The invasive nature of bone marrow biopsy must be weighed against the diagnostic yield, particularly when blood cultures are readily available and highly sensitive. 5, 6

Practical Diagnostic Algorithm

For suspected disseminated MAC in HIV patients with CD4 <50 cells/µL: 1, 2, 5

  1. Obtain blood cultures first—these detect >90% of cases and are less invasive 2

  2. Consider bone marrow examination if:

    • Two blood cultures are negative but clinical suspicion remains high 2
    • Rapid diagnosis is needed (histology provides results in 1-2 days vs. 16-19 days for culture) 6
    • Patient has high fever, prolonged febrile course, or elevated direct bilirubin 5

  3. If bone marrow is performed, request:

    • Aspirate for culture (equal sensitivity to blood culture) 5
    • Core biopsy for histopathology with AFB staining 6
    • Consider immunohistochemical staining if available (superior sensitivity) 7

  4. If isolated lymphadenopathy without bacteremia, pursue excisional biopsy of accessible nodes rather than bone marrow. 2

References

2
Guideline

Clinical Manifestations of Nontuberculous Mycobacterial (NTM) Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Research

The bone marrow in disseminated Mycobacterium avium-intracellulare infection.

American journal of clinical pathology, 1985

Related Questions

How should bone manifestations of disseminated Mycobacterium avium complex be treated?
How do you contract Mycobacterium avium complex (MAC) infection?
What are the precautions and treatment options for Mycobacterium Avium Complex (MAC) infection?
Why is the acid‑fast bacilli (AFB) smear not helpful in diagnosing Mycobacterium avium‑intracellulare (MAI) infection?
What are the recommended dosing, contraindications, and monitoring parameters for bumetanide in adults, including elderly patients or those with reduced renal function?
Should the patient continue daily Descovy (emtricitabine/tenofovir alafenamide) until after the second Apretude (cabotegravir) injection, which is scheduled about four weeks after the first injection?
What is the 12‑month prognosis for a patient with Stiff Person Syndrome (SPS)?
When should oral sodium chloride tablets be started in a patient with SIADH who has chronic mild‑to‑moderate hyponatraemia, mild or no neurological symptoms, and inadequate fluid restriction?
In an otherwise healthy adult with acute sinusitis, can the infection cause nausea and diarrhea?
What does clay‑colored (pale gray‑white) stool in an infant indicate and what urgent evaluation and management steps are required?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.